HNRNPH1

Heterogeneous nuclear ribonucleoprotein H · P31943 · HNRNPH1 on Sugi Atlas →

0 patent compounds predicted against HNRNPH1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPH1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD PHASE1/PHASE2RECRUITING
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
An In Vivo Model for Postinflammatory Hyperpigmentation nanCOMPLETED
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes nanRECRUITING
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma nanRECRUITING
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a HNRNPH1 binder may also engage these)

ProteinNameSimilarity
O35737 1.000 O35737 →
Q8VHV7 1.000 Q8VHV7 →
Q3SZF3 1.000 Q3SZF3 →
P70333 0.996 P70333 →
P55795 0.994 P55795 →
Q5RD26 0.994 Q5RD26 →
Q6AY09 0.987 Q6AY09 →
Q60HC3 0.945 Q60HC3 →
Q794E4 0.944 Q794E4 →
Q5E9J1 0.942 Q5E9J1 →
Q8R081 0.934 Q8R081 →
HNRNPL Heterogeneous nuclear ribonucleoprotein L 0.933 landscape →
HNRNPF Heterogeneous nuclear ribonucleoprotein F 0.933 landscape →
Q9Z2X1 0.931 Q9Z2X1 →
F1LQ48 0.927 F1LQ48 →
O14639 0.919 O14639 →
Q96SI9 0.916 Q96SI9 →
Q9FGL9 0.916 Q9FGL9 →
Q08E27 0.915 Q08E27 →
Q8JH47 0.914 Q8JH47 →
Q5R6Y5 0.914 Q5R6Y5 →
Q5PYH5 0.913 Q5PYH5 →
Q61187 0.912 Q61187 →
HNRNPLL Heterogeneous nuclear ribonucleoprotein L-like 0.912 landscape →
Q91YE7 0.911 Q91YE7 →
Q8R3L8 0.911 Q8R3L8 →
Q91WM1 0.910 Q91WM1 →
P50904 0.910 P50904 →
Q9P2K5 0.910 Q9P2K5 →
Q62696 0.910 Q62696 →